MiR-199a-3p regulates HCT-8 cell autophagy and apoptosis in response to Cryptosporidium parvum infection by targeting MTOR.
Shanbo WuTianren ShaoJingjing XieJuanfeng LiLulu SunYafang ZhangLijie ZhaoLuyang WangXiaoying LiLongxian ZhangRongjun WangPublished in: Communications biology (2024)
The microRNAs (miRNAs) of their hosts play an important role in regulating both the innate and adaptive immune responses to Cryptosporidium parvum infection. The mechanisms of autophagy and apoptosis are important components of the defense system against C. parvum infection. In this study, we investigate the role of miRNA-199a-3p in regulating MTOR-mediated autophagy and apoptosis in HCT-8 cells induced by C. parvum. The expression of miR-199a-3p increased at 3, 6 and 12 hours postinfection (hpi) but decreased at 24 and 48 hpi. The upregulation of miR-199a-3p promoted autophagy and apoptosis and limited the parasite burden in HCT-8 cells after C. parvum infection. The downregulation of miR-199a-3p inhibited the autophagy and apoptosis induced by C. parvum and enhanced the parasite burden in HCT-8 cells. A luciferase reporter showed that MTOR was a target gene of miR-199a-3p. Suppressed expression of MTOR by small interfering RNA (siRNA) promoted autophagy and apoptosis and limited C. parvum burden in HCT-8 cells. Co-transfection with miR-199a-3p inhibitor or si-mTOR revealed that miR-199a-3p regulates autophagy and apoptosis in HCT-8 cells through MTOR, to resist C. parvum infection. In conclusion, intestinal epithelial cells defend against C. parvum infection by regulating their autophagy and apoptosis through the miR-199a-3p-MTOR axis.
Keyphrases
- cell cycle arrest
- cell death
- endoplasmic reticulum stress
- induced apoptosis
- pi k akt
- signaling pathway
- cell proliferation
- oxidative stress
- immune response
- poor prognosis
- stem cells
- drug delivery
- crispr cas
- single cell
- bone marrow
- transcription factor
- room temperature
- inflammatory response
- ionic liquid
- mesenchymal stem cells
- copy number
- cell therapy
- binding protein
- hyaluronic acid